Sumatriptan Succinate recalls
Sumatriptan Succinate products have been recalled 2 times, most recently on 15 Jun 2022. The recalling company is usually Mckesson Medical-Surgical Inc. Corporate Office. The most common reason is potency & assay.
Total recalls2since 2020
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why sumatriptan succinate is recalled
Companies
By year
All sumatriptan succinate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Sumatriptan Succinate Tablets, 100 mg, 9-of- use tablets recalledSumatriptan Succinate | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Sumatriptan Succinate Tablets, 50 mg recalledSumatriptan Succinate | Sun Pharmaceutical Industries | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.